XGN Exagen Inc

1.96

-0.02 (-1.01%)

15 Jun 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Exagen Inc	NASDAQ:XGN	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.02	-1.01%	1.96	1.86	2.01	1.96	1.89	1.95	44,492	01:00:00

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

08/03/2024 2:00pm

GlobeNewswire Inc.

Exagen (NASDAQ:XGN)
Historical Stock Chart

From Dec 2023 to Jun 2024

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings with investors and a fireside chat on Wednesday, March 20, at 1:30 PM ET.

About Exagen Inc.Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Contact:Ryan DouglasExagen Inc.ir@exagen.com760.560.1525